🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The American Society of Nephrology seeks applications for Editor-in-Chief of Kidney360, one of three journals in the ASN portfolio which also includes JASN and CJASN. Learn more about the position and the application process here: journals.lww.com/asnjournals/pa…

Kidney360’s mission is to publish scientifically rigorous research that includes content from all disciplines of kidney science. The editors have selected five Editors’ Choice Articles to highlight the outstanding quality and broad spectrum of published content from 2024. Find

Editors’ Choice 2024: Senescence in Heme Protein–Induced Acute Kidney Injury This study found that the pathogenesis of HP-AKI involves senescence and the induction of p16Ink4a, the latter driven, in part, by hemoglobin, myoglobin, and heme. bit.ly/KID0395 Vesna Garovic

Editors’ Choice 2024: Tumor Necrosis Factor from the Proximal Nephron Exacerbates Aristolochic Acid Nephropathy Aristolochic acid nephropathy (AAN) presents with tubular epithelial cell (TEC) damage and tubulointerstitial inflammation. This study found that TNF from the proximal

Your Basic Research deserves the spotlight! Did you know that JASN® and Kidney360® are eager to publish your basic research? Start your submission. ow.ly/UNGA50UMuKl JASN_News ASN Kidney360

Editors’ Choice 2024: Continuous Glucose Monitoring and Diabetes-Related Hospitalizations in Patients with Type 2 Diabetes and Kidney Disease There is a heightened risk of glycemic variability in patients with diabetes and CKD. This study found that initiation of CGM was

Editors’ Choice 2024: Is Gastric Acid Suppression Therapy Linked with Peritoneal Dialysis–Associated Peritonitis? Peritonitis is a major peritoneal dialysis–related complication. This study found that the association between GAS use and peritonitis risk was weaker than for

Editors’ Choice 2024: Kidney Outcomes with Sodium-Glucose Co-transporter 2 Inhibitor Initiation after Acute Kidney Injury among Veterans with Diabetic Kidney Disease This study found that SGLT2i use was associated with a lower risk for CKD progression and for recurrent AKI among

Apply now for Editor-in-Chief of ASN Kidney360! Lead the direction of cutting-edge kidney research and shape the future of nephrology. Applications close Friday, January 31, 2025, at 4 p.m. EST. Don’t miss this opportunity—apply today! Learn more: bit.ly/Kidney360EIC

Beginning February 3, we will no longer actively post on this account. Follow us on ASN Publications (currently CJASN) for the latest from ASN publications, including JASN, CJASN, Kidney360, and Kidney News.

Life Years from Transplant (LYFT) is a measure of the predicted difference between the expected lifespan with and without a kidney transplant. This study found that less homogenous metrics with meaningful disaggregation are needed to inform institutional evaluation and policy

This study found that intraperitoneal phloretin therapy followed a distinct dose-response relationship, showing high potency in improving ultrafiltration and reducing glucose absorption in experimental PD. bit.ly/KID0717 Carl Öberg MD PhD

Beginning February 3, we will no longer actively post on this account. Follow us on ASN Publications (currently CJASN) for the latest from ASN publications, including JASN, CJASN, Kidney360, and Kidney News.

Honored to contribute an editorial to ASN Kidney360 on the insightful study by Nath et al. in the latest issue ! 👏 UofU Nora Eccles Harrison CVRTI University of Utah Nephrology Senescent Cells: An Emerging Therapeutic Target for... : Kidney360 journals.lww.com/kidney360/full…

The American Society of Nephrology seeks applications for Editor-in-Chief of Kidney360, one of three journals in the ASN portfolio which also includes JASN and CJASN. Learn more about the position and the application process here: journals.lww.com/asnjournals/pa…

Beginning February 3, we will no longer actively post on this account. Follow us on ASN Publications (currently CJASN) for the latest from ASN publications, including JASN, CJASN, Kidney360, and Kidney News.

This article provides a comprehensive review of MTX metabolism, mechanisms and prevention of MTX-AKI, and its management. bit.ly/KID0725

Beginning February 3, we will no longer actively post on this account. Follow us on ASN Publications (currently CJASN) for the latest from ASN publications, including JASN, CJASN, Kidney360, and Kidney News.